Overview

Senseonics, Incorporated is a medical technology company headquartered in Germantown, Maryland, founded in 1996 and publicly traded under the ticker SENS. It employs roughly 100 to 200 people and develops continuous glucose monitoring systems, including its Eversense platform, which uses a long-term implantable sensor for diabetes patients. The company serves the medical industry and reported annual revenue of about $35.3 million. In September 2026, it was reported that Eversense 365 integration with the iLet Bionic Pancreas was planned.

At a glance

What Senseonics, Incorporated makes

The company holds ISO 13485 certification and markets an implantable glucose sensor used in its Eversense continuous glucose monitoring system.

Products and capabilities described on the company's own site include Sensor (source: senseonics.com).

Certifications

Senseonics, Incorporated is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:

• ISO 13485 — senseonics.com

Latest developments

• 2026-09-14 — Eversense 365, iLet Bionic Pancreas Integration Planned (mddionline.com)

• 2026-08-13 — Inside Senseonics’ commercial overhaul and what’s next | MedTech Dive (medtechdive.com)

• 2026-05-07 — Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results – Senseonics (senseonics.com)

• 2026-05-04 — Senseonics Enters Into Amended Loan Agreement with Hercules (globenewswire.com)

• 2026-02-19 — Sequel Med Tech and Senseonics Launch Transformative Combination of twiist™ and Eversense® 365 – Senseonics (senseonics.com)

• 2026-01-30 — Senseonics wins CE mark for one-year CGM | MedTech Dive (medtechdive.com)

Company details

Senseonics reported first quarter 2026 financial results on May 7, 2026, and is listed publicly on a U.S. exchange. Senseonics, Incorporated was founded in 1996, has an estimated 100-200 employees, and is headquartered in Germantown, Maryland. On the LightSource stability read it is rated "Established & strong": 30 years in operation (founded 1996). Publicly listed; no distress event on record. Holds ISO 13485 certification(s) per public sources.

Frequently asked questions

What does Senseonics, Incorporated make?

Senseonics, Incorporated is a medical technology company headquartered in Germantown, Maryland, founded in 1996 and publicly traded under the ticker SENS. It employs roughly 100 to 200 people and develops continuous glucose monitoring systems, including its Eversense platform, which uses a long-term implantable sensor for diabetes patients. The company serves the medical industry and reported annual revenue of about $35.3 million. In September 2026, it was reported that Eversense 365 integration with the iLet Bionic Pancreas was planned.

Where is Senseonics, Incorporated headquartered?

Senseonics, Incorporated is headquartered in Germantown, Maryland (20451 Seneca Meadows Parkway, Germantown, Maryland, 20876).

When was Senseonics, Incorporated founded?

Senseonics, Incorporated was founded in 1996.

How big is Senseonics, Incorporated?

Senseonics, Incorporated has an estimated 100-200 employees, with revenue in the 35.3M range.

Is Senseonics, Incorporated publicly traded?

Publicly traded (NASDAQ: SENS). Public financial figures are drawn from its filings.

What certifications does Senseonics, Incorporated hold?

Senseonics, Incorporated lists ISO 13485 on its website. Confirm the certified scope for the specific plant producing your part.

Related suppliers

Explore other suppliers in the LightSource directory:

• 10xEngineers

• 1X

• 365 Retail Markets

• 3Com

• 3PAR

Last verified Nov 2026. Is this your company? Request a correction.